The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

MedTech Innovator is a nonprofit global competition and accelerator based in Los Angeles, California, founded in 2013. It focuses on supporting companies in the medical device, digital health, and diagnostic sectors. The organization aims to enhance patient outcomes by fostering the growth of businesses that contribute to the transformation of the healthcare system. Each year, MedTech Innovator showcases 100 companies that align with key themes identified through surveys of industry leaders. The accelerator's diverse portfolio includes firms involved in consumer healthcare, imaging, remote patient monitoring, clinical studies, and workflow optimization, emphasizing its commitment to advancing innovative healthcare solutions.

SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.

The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.

MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, established in 2009. It supports early-stage entrepreneurs across various industries, including technology, healthcare, and social impact, by providing mentorship, resources, and networking opportunities. With locations in Israel, Mexico, Switzerland, Texas, and the UK, MassChallenge connects high-potential startups with industry experts and investors to foster innovation and facilitate growth. The accelerator operates on a non-equity model, allowing entrepreneurs to maintain full ownership of their companies while benefiting from strategic partnerships and tailored training programs. Through its diverse initiatives, such as targeted accelerator programs like MassChallenge HealthTech and FinTech, the organization aims to drive impactful change and enhance the global innovation ecosystem.

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

EASME is a European Union executive agency that supports small and medium-sized enterprises and promotes innovation in Europe. It manages projects in the areas of small and medium-sized enterprises, as well as the environment, energy, and maritime sectors, funded by COSME, LIFE, and EMFF. EASME organizes the European Sustainable Energy Week and serves industries such as environmental management, energy production, and maritime activities.

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

HAX is a venture capital program focused on accelerating hardware startups through its comprehensive support and resources. Founded in 2012 and headquartered in Newark, New Jersey, HAX operates in two key locations, San Francisco and Shenzhen, providing founders with an environment conducive to rapid prototyping and iterative development. The program emphasizes the importance of launching both B2C and B2B hardware startups, guiding them through critical phases such as business development, fundraising, and market entry. HAX accepts teams that demonstrate strong potential for scaling their ventures and solving significant technological challenges. Through a structured curriculum, entrepreneurs refine their product-market fit and business strategies while benefiting from a robust network of mentors and industry connections. HAX maintains an ongoing relationship with participating startups to support their growth beyond the initial program, ensuring they have the necessary resources and partnerships to succeed in the competitive marketplace.

Innovate UK is a non-departmental public body established in 2007 and based in Swindon, United Kingdom. Funded by a government grant, it supports innovation in science and technology by providing funding services to businesses across various sectors and regions. The organization aims to drive productivity and economic growth by facilitating advancements that contribute to the UK’s economic landscape. In addition to funding, Innovate UK offers a range of services and information related to business and economic development, thereby fostering a supportive environment for innovation.

Venture Kick is a private philanthropic initiative based in Zurich, Switzerland, founded in 2007 to support Swiss startups at the pre-seed stage. It provides up to 150,000 Swiss francs in funding and offers structured entrepreneurial training aimed at developing sustainable businesses. Entrepreneurs participate in a competitive process, pitching their ideas up to three times for increasing funding amounts, while receiving valuable feedback from expert juries. To date, Venture Kick has supported 600 startup projects with a total of 24.9 million francs, leading to the incorporation of 454 active companies that have created over 6,000 jobs and attracted approximately 2.49 billion francs in subsequent investments. Companies founded by Venture Kick alumni have notably achieved significant recognition, with 55 percent of the TOP 100 Swiss Startup Award in 2018 represented by these ventures. In 2019, the initiative aimed to allocate 4.35 million francs to support idea-stage projects, facilitating the transition of Swiss scientific innovations to global markets.

OrbiMed is a healthcare-focused investment firm based in New York City, established in 1989. The firm specializes in providing a range of financing solutions, including bridge loans, senior debt, and structured debt capital for both commercial-stage public and private healthcare companies. OrbiMed invests across various sectors within the healthcare industry, such as pharmaceuticals, life sciences, digital health, medical devices, biopharmaceuticals, diagnostics, healthcare technology, and biotechnology. With approximately $5 billion in assets under management, OrbiMed aims to support a spectrum of healthcare companies, from early-stage ventures to established multinational corporations.

Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.

New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, headquartered in Menlo Park, California, with additional offices in the U.S., India, and China. NEA specializes in investing in technology and healthcare sectors, with a focus on enterprise, consumer, fintech, life sciences, and digital health companies. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. NEA invests globally, with a significant presence in Asia, including China and India, as well as the United States. The firm typically invests between $0.05 million and $20 million per deal.

The U.S. Department of Energy is a government agency established in 1977, located in Washington, D.C. Its primary mission is to ensure the security and prosperity of the nation by tackling energy, environmental, and nuclear challenges. The Department focuses on promoting transformative scientific and technological solutions to address these issues, thereby supporting the country's energy needs and environmental sustainability.

Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.

Medtronic is a global leader in healthcare technology, specializing in innovative solutions for complex medical conditions. The company offers a wide range of treatments and therapies, including patient monitoring systems, robotic surgery, insulin pumps, and cardiac devices, catering to various health areas such as lungs, brain, diabetes, heart, and orthopedics. Medtronic's extensive portfolio addresses 70 different medical conditions, aiming to improve and extend the lives of patients worldwide.

The European Investment Bank (EIB), established in 1958, is a long-term lending institution owned by the EU Member States. Headquartered in Luxembourg, it offers a wide range of financing solutions, including project loans, loans to banks and intermediaries, venture capital funds, and equity investments. EIB also provides structured finance products, guarantees, and securitization instruments, along with advisory services for infrastructure projects, urban development, and small to medium-sized enterprises. Its portfolio is predominantly composed of loans (93.08%), with a small portion allocated to debt and fixed income, shares, and other assets. EIB's mission is to support European integration and social cohesion, primarily within the European Union and internationally.

Perceptive Advisors, established in 1999, is a New York-based investment management firm specializing in the life sciences sector. It invests in both private and public biotechnology, pharmaceutical, medical device, diagnostics, and health services companies across their lifecycle, from seed and early-stage ventures to public equities. The firm employs a long/short equity strategy and conducts in-house research to identify promising opportunities. Perceptive Advisors also offers customized debt financing solutions through its Perceptive Credit Opportunities Fund.

Ben Franklin Technology Partners of Southeastern Pennsylvania, established in 1982, is a non-profit organization that fosters technological innovation and growth in the region. It primarily invests in early-stage technology companies, having supported over 1,750 such ventures since its inception. The organization also facilitates university-industry partnerships to accelerate scientific discoveries to market, and initiates regional programs to bolster the entrepreneurial ecosystem. Its mission is to create jobs and transform lives by leading the region's technology community to new heights.

Legend Capital, established in 2001, is a Beijing-based venture capital firm and subsidiary of Legend Holdings Ltd. It manages multiple funds totaling up to US$700 million, focusing on early-stage IT companies and mid-market growth stage companies in China. Its investment sectors include network applications and services, outsourcing, professional services, IC design, key components, consumer goods, clean technology, healthcare, and modern services. Legend Capital actively supports its portfolio companies, providing business resources and tailored services to facilitate growth and enhance returns. Notable portfolio companies include Joyo.com (acquired by Amazon.com) and Spreadtrum Communications (Nasdaq: SPRD).

TEDCO is an independent organization established in 1998 and located in Columbia, Maryland. It serves as the leading source of entrepreneurial business assistance and seed funding for the development of startup companies within Maryland's innovation economy. TEDCO focuses on early-stage companies across various sectors, including software, technology, energy equipment, life sciences, and oncology. Its mission is to foster innovation and economic growth in Maryland by supporting the growth of startups and enhancing the state's position in the entrepreneurial landscape.

Gilde Healthcare, established in 1982 and headquartered in Utrecht, Netherlands, is a leading venture capital firm specializing in the healthcare sector. With over €800 million under management, the firm invests in digital health, diagnostics, medical devices, therapeutics, and healthcare services across Europe and North America. Gilde focuses on growth capital and buyout opportunities, typically investing between €1 million and €40 million per transaction, with a preference for majority or significant minority stakes. The firm seeks to be the lead investor and take a board seat, aiming to exit through IPOs, strategic sales, or private placements. Gilde's portfolio spans various healthcare sub-sectors, with a particular emphasis on cardiology, oncology, and women's health.

U.S. Venture Partners (USVP), founded in 1981 and based in Menlo Park, California, is a venture capital firm that specializes in early-stage investments. The firm focuses on transformative ideas within the information technology and healthcare sectors, emphasizing innovation that drives economic growth and job creation. USVP's investment areas include enterprise software, IT security, consumer internet, mobile applications, e-commerce, healthcare, and IT-enabled healthcare services. The team at USVP comprises former entrepreneurs, technologists, corporate executives, financial professionals, and industry experts, all dedicated to supporting entrepreneurs in their journey to build impactful companies. The firm primarily targets businesses located on the West Coast of the United States, seeking opportunities in B2B, life sciences, oncology, cybersecurity, digital health, and cloud technology.

Enterprise Ireland is a government agency based in Dublin, Ireland, established in 1998 to foster the growth and development of indigenous businesses. Its primary mission is to assist Irish enterprises in achieving a strong presence in global markets, thereby enhancing national and regional prosperity. The agency supports a wide range of companies, from high-potential start-ups to established businesses, by providing funding, resources, and guidance. Additionally, Enterprise Ireland collaborates with college-based researchers to facilitate the development and commercialization of innovative technologies through licensing and spin-out companies. By focusing on innovation and export sales, Enterprise Ireland plays a crucial role in driving economic growth and competitiveness within the Irish economy.

Sofinnova Partners, established in 1972 and headquartered in Paris, is a leading venture capital firm focused on the life sciences sector. It manages over €2 billion, investing from seed to later-stage in biopharmaceuticals, medical devices, and industrial biotechnology. The firm proactively sources deals, often leading financings and actively supporting portfolio companies until exit. Sofinnova Partners invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations, playing a significant role in developing transformative innovations that can positively impact the future.

EQT is a global private equity and infrastructure firm founded in 1994, headquartered in Stockholm, Sweden. It specializes in buyouts, expansion capital, and infrastructure investments, focusing on mid-market companies with strong growth potential. EQT invests across various sectors, including healthcare, technology, services, industrials, and real estate, with a particular emphasis on Northern and Eastern Europe, Asia, and the US. The firm seeks to unlock growth potential in its portfolio companies, positioning them as sustainable market leaders, and typically holds investments for four to eight years. EQT also prioritizes ESG and impact investments in its infrastructure portfolio.

Innovation Works is a venture capital firm based in Pittsburgh, Pennsylvania, established in 1999. With over 20 years of experience, it has become a key player in Southwestern Pennsylvania's technology economy, focusing on investing in high-potential companies that can significantly impact the regional economy. As the largest investor in seed-stage companies in the region, Innovation Works supports a diverse range of sectors, including robotics, artificial intelligence, medical devices, retail technologies, and enterprise software. In addition to financial investment, the firm offers business expertise and resources to help manufacturers adopt new technologies, further fostering innovation and growth within the local economy.

Johnson & Johnson Innovation - JJDC, established in 1973 and based in New Brunswick, New Jersey, serves as the corporate venture capital arm of Johnson & Johnson. The organization focuses on accelerating early-stage innovation by fostering strategic collaborations. JJDC connects potential partners with essential resources to support advancements in transformation science and technology across various sectors, including pharmaceuticals, medical devices, consumer healthcare, and medtech. Through its investment activities, JJDC aims to drive innovation and enhance the development of new solutions that can improve health and well-being.

Novo Holdings, established in 1999, is a Danish asset management firm based in Copenhagen. It serves as the investment arm of the Novo Nordisk Foundation, managing its assets and wealth. The company's primary focus is the life science sector, with a diversified portfolio comprising equities, bonds, real estate, infrastructure, and private investments. Novo Holdings maintains a significant influence on Novo Nordisk A/S and Novozymes A/S, ensuring these companies align with the Novo Group's visions and values. It also invests in early and growth-stage life science companies through its venture capital arm, Novo Ventures, which targets investments ranging from USD 5 million to USD 30 million.

Scottish Enterprise, established in 1991, is Scotland's principal economic development agency, operating as a non-departmental public body of the Scottish Government. Its mission is to stimulate Scotland's economic growth by fostering an innovative, high-wage, and productive economy with a strong international presence. The agency partners with both public and private sectors to identify and capitalize on opportunities that drive significant, lasting economic impact. Scottish Enterprise provides comprehensive support to businesses, including helping companies secure appropriate finance, strengthening management teams, and facilitating growth and export initiatives. It works closely with Scottish SMEs, as well as UK and international investors, such as business angels, venture capital groups, and corporate investors. The agency operates across Scotland in collaboration with Highlands and Islands Enterprise, aiming to increase the supply of finance for businesses and support the SME funding market.

High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.

Panakes Partners, established in 2015, is a Milan-based venture capital firm focused on early-stage investments in the life sciences sector. The company, founded by Fabrizio Landi, Alessio Beverina, and Diana Saraceni, invests in ambitious startups and teams across Europe and Israel, aiming to support revolutionary technologies and products that improve global health. With 250 million under management, Panakes Partners seeks to foster innovation and growth in the life sciences and healthcare industries.

SV Health Investors, established in 1993, is a prominent venture capital firm headquartered in Boston, Massachusetts. With over $2 billion in assets under management across seven private healthcare funds, the firm invests in innovative healthcare and life sciences companies across the United States and Europe. SV Health Investors focuses on supporting entrepreneurs developing breakthrough treatments and technologies, with a particular interest in therapeutics, biotechnology, healthcare services, and medical technology. The firm aims to transform healthcare through strategic investments, leveraging its 20-year track record and offices in Boston, San Francisco, and London.

The Bill & Melinda Gates Foundation is an independent non-profit organization based in Seattle, Washington, established in 2000. It is dedicated to reducing global inequities by focusing on improving health, alleviating extreme poverty, and supporting educational initiatives. The foundation also engages in community giving within the Pacific Northwest, promoting strategies and programs that assist low-income families. With regional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom, the foundation is governed by its co-founders, Bill and Melinda Gates, along with trustee Warren Buffett. Its mission encompasses a wide range of global challenges, aiming to create lasting change through targeted grant-making and programmatic efforts.

Lilly Asia Ventures, established in 2008 and based in Shanghai, China, serves as the corporate venture capital arm of Eli Lilly and Company. The firm focuses on making investments in promising life science companies that exhibit strong management teams and innovative technologies or business models. While its primary investment strategy targets opportunities in China, Lilly Asia Ventures is also open to exploring prospects in other regions of East and South Asia. The firm invests across various stages, including seed, early, and later stages, with particular interest in sectors such as healthcare, life sciences, oncology, manufacturing, and technology-based industries. Through its investments, Lilly Asia Ventures aims to foster the development of innovative solutions that contribute to improved health and quality of life.

Google.org is a philanthropic arm of Google, a multinational technology company. It funds and supports nonprofits globally, providing them with funding, tools, and volunteers. Google.org has committed approximately $100 million annually to these efforts, aiming to extend the reach of innovative nonprofits and create lasting global impact.

IndieBio, established in 2014, is a San Francisco-based accelerator firm specializing in Synthetic Biology. It runs intensive four-month programs for early-stage companies and teams with innovative biological concepts. IndieBio invests in seed and early-stage startups globally, focusing on those that use biology as their core technology to solve real-world problems. The firm typically invests $250k, with an initial cash investment of $50k in exchange for an 8% equity stake. It prefers teams with at least two co-founders. IndieBio was the world's first accelerator dedicated to biology-based startups, aiming to address global challenges through innovative biotechnology.

HSG, formerly known as Sequoia Capital China, is a global venture capital and private equity firm, managing over USD 55 billion across various funds. Established in 2005, HSG invests in technology, healthcare, and consumer sectors, with a focus on seed, venture, growth, buyout, and infrastructure stages. The firm has backed over 1,500 companies, with more than 160 listed on public exchanges and over 140 achieving unicorn status. HSG operates globally, with offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, providing extensive resources and industry expertise to its portfolio companies.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

Sand Hill Angels, established in 2000, is a prominent angel investor group based in Mountain View, California, comprising over 60 successful Silicon Valley technology professionals. The group is dedicated to supporting and growing startup companies, with a focus on seed-stage technology investments across North America. They typically invest between $300,000 to $500,000 in private companies, with a pre-money valuation of less than $5 million. Sand Hill Angels' investment preferences span various sectors, including clean technology, Internet startups, information sciences, and life sciences, with a particular interest in semiconductors, enterprise software, storage, communications, medical devices, diagnostics, and bioinformatics. The group collaborates openly with venture capital funds, other angel organizations, and the broader Bay Area ecosystem to foster the growth of technology startups.

Deerfield Management, established in 1994 and headquartered in New York, is a healthcare-focused investment management firm. It provides long-term structured investments in both public and private healthcare companies, spanning life science, medical device, diagnostic, digital health, and health service industries. The firm also offers information and investment services to foster a healthcare ecosystem.

HealthTech Capital is an angel investment group based in Los Altos Hills, California, founded in 2010. The group focuses on funding and mentoring emerging health-tech startups that operate at the intersection of healthcare, technology, and mobility. By fostering collaboration among leading clinical providers, venture firms, and other strategic industry players, HealthTech Capital aims to create a robust ecosystem that supports innovative solutions in the health sector.

Versant Ventures, established in 1999, is a global healthcare investment firm headquartered in San Francisco, California. With over $2.3 billion under management and offices in North America and Europe, the firm invests across the healthcare sector, with a focus on discovering and developing novel therapeutics. Versant's team, comprising deep investment, operating, and scientific expertise, takes a hands-on approach to company building. Since inception, over 65 Versant companies have achieved successful acquisitions or IPOs.

Kohlberg Kravis Roberts (KKR) is a global investment firm established in 1976, headquartered in New York. It manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, and credit. Through strategic partnerships, KKR also invests in hedge funds. The firm employs a patient and disciplined approach, focusing on long-term value creation and generating attractive returns for its fund investors across various sectors such as business services, consumer products, energy, financial services, and technology.

Shenzhen Capital Group Co., Ltd (SCGC) is a venture capital firm founded in 1999 by the Shenzhen Government. The company is dedicated to fostering national industries, developing national brands, and promoting economic transformation through investments in emerging sectors. SCGC primarily targets small to medium enterprises and innovative high-tech companies, focusing on those in various stages of growth, including startups and those undergoing transformation. Its investment portfolio spans industries that align with national policy support, such as information technology, internet services, new media, biopharmaceuticals, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With a registered capital of 5.42 billion RMB and significant assets under management, SCGC has established itself as a leader in the venture capital landscape, having invested in numerous companies, many of which have achieved public listings across global capital markets.

Ally Bridge Group is a healthcare-focused private investment group founded in 2013, with operations in Hong Kong and the United States. The firm specializes in venture and growth capital, buyout, and hedge fund investing, primarily targeting life sciences companies and innovative medical technologies. With a commitment to bridging the gap between groundbreaking healthcare innovations and global markets, Ally Bridge Group invests in both private and public equity across various sectors, including medical devices and biopharmaceuticals. By leveraging its extensive expertise and network, the firm aims to support the development and growth of its portfolio companies, focusing on transformative solutions that address significant unmet medical needs.

T. Rowe Price Group, Inc., established in 1937 and headquartered in Baltimore, Maryland, is a global investment management firm. It serves a diverse range of clients, including individuals, institutional investors, retirement plans, and financial intermediaries. The company offers a broad spectrum of investment strategies, focusing on equity and fixed income markets worldwide. T. Rowe Price employs a fundamental, bottom-up approach, combining in-house and external research, and considers environmental, social, and governance factors in its investment decisions. With offices across North America, Europe, Asia, and Australia, the firm is committed to delivering long-term investment excellence.

Lumira Ventures, established in 2007, is a prominent North American venture capital firm specializing in healthcare and life sciences investments. Based in Toronto, with additional offices in Montreal, Vancouver, and Boston, the firm focuses on emerging, mid, and late-stage companies in biotechnology, biopharmaceuticals, medical devices, digital health, and consumer health sectors. Lumira Ventures invests between $5 million to $15 million, providing not only capital but also active board participation, access to funding sources, partners, and market access to maximize the value of its portfolio companies' technology pipelines. With a 30-year history, the firm has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies across Canada and the United States.